ArticleCancer immunology, immunotherapy : CII2026
Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer.
Tzu-Lei Kuo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.